US Stock Insider Trading | Surrozen Disclosed Six Insider Transactions on March 16

K-LinePoet · 2026-03-24T15:03:06+00:00

Surrozen (SRZN) disclosed multiple insider transactions on March 16, 2026, with major shareholders including TCG Crossover GP II, LLC continuing to increase their holdings, with significant total transaction amounts. The company focuses on developing biopharmaceuticals that modulate the Wnt pathway for applications across multiple diseases.

K-LinePoet

2026-03-24 15:03:06

Abstract generation in progress

On March 16, 2026, Surrozen (SRZN) disclosed six insider trading transactions. Shareholder owning more than 10%, TCG Crossover GP II, LLC, purchased 17,700 shares on March 16, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
March 16, 2026	Shareholder >10%	TCG Crossover GP II, LLC	March 16, 2026	Buy	1,190	24.99	$29,700
March 16, 2026	Shareholder >10%	TCG Crossover GP II, LLC	March 12, 2026	Buy	12,400	24.99	$309,200
March 16, 2026	Shareholder >10%	TCG Crossover GP II, LLC	March 13, 2026	Buy	35,400	24.88	$881,520
February 12, 2026	Shareholder >10%	TCG Crossover GP II, LLC	February 12, 2026	Buy	1,093	23.86	$26,085
February 11, 2026	Shareholder >10%	TCG Crossover GP II, LLC	February 11, 2026	Buy	17,800	23.58	$419,004
February 2, 2026	Shareholder >10%	TCG Crossover GP II, LLC	February 2, 2026	Buy	731	21.38	$15,626
February 3, 2026	Shareholder >10%	TCG Crossover GP II, LLC	February 3, 2026	Buy	4,355	21.94	$95,560
January 30, 2026	Shareholder >10%	TCG Crossover GP II, LLC	January 30, 2026	Buy	4,271	21.39	$91,340
January 15, 2026	Shareholder >10%	Kutzkey Tim	January 15, 2026	Buy	11,900	19.89	$236,985
January 16, 2026	Shareholder >10%	Kutzkey Tim	January 16, 2026	Buy	2,562	20.00	$51,240

【Company Information】

Surrozen, Inc. is a biotechnology company incorporated in Delaware, established on August 21, 2020. The company focuses on discovering and developing candidate drugs that selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies aimed at leveraging the body’s existing regenerative mechanisms, with potential applications across various disease areas including the gastrointestinal tract, liver, retina, cornea, lungs, kidneys, cochlea, skin, pancreas, and central nervous system.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.